epigallocatechin gallate has been researched along with Stomach Neoplasms in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (7.69) | 18.2507 |
| 2000's | 5 (19.23) | 29.6817 |
| 2010's | 14 (53.85) | 24.3611 |
| 2020's | 5 (19.23) | 2.80 |
| Authors | Studies |
|---|---|
| Cen, J; Dong, J; Huang, J; Huang, K; Liang, Y; Lu, X; Pan, Y; Shu, G; Ye, S; Ye, W; Zhang, J; Zheng, Z; Zhou, M | 1 |
| Aboulkheyr Es, H; Alikhani, M; Alipour Choshali, M; Ebrahimi, M; Farzaneh, Z; Najimi, M; Piryaei, A; Shahriari Felordi, M; Vosough, M | 1 |
| Chen, X; Jiang, J; Wan, X; Wang, Y; Xu, P; Zhao, Y | 1 |
| Cheng, B; Liu, X; Lv, J; Rui, X; Wu, M; Xue, M | 1 |
| Bae, SJ; Ha, KT; Han, JH; Jang, SB; Kim, HJ; Kim, M; Lee, IK; Ryu, D | 1 |
| Feng, A; He, Y; Li, X; Yuan, X; Zheng, W; Zhou, G | 1 |
| Cui, WG; Ding, LY; Fan, KY; Fu, JD; Leng, J; Wang, H; Yao, JJ | 1 |
| Li, G; Ma, J; Shi, M; Wang, N; Wang, T; Wang, Y; Wei, J | 1 |
| Bai, J; Cai, M; Chen, J; Ma, M; Shuai, X; Tao, K; Wang, G; Xu, F | 1 |
| Chen, ZR; Feng, CL; Hsieh, CH; Lai, CH; Lin, YH | 1 |
| Du, W; Yang, C; Yang, D | 1 |
| Bai, L; Chen, J; Jin, L; Li, M; Liang, Z; Lu, C; Lu, L; Tang, H; Tang, L; Wang, K; Wu, R; Yan, Y; Ye, Y | 1 |
| Cai, SR; He, YL; Wang, Z; Zhan, WH; Zhang, CH; Zhu, BH | 1 |
| Bomser, JA; Ferruzzi, MG; Green, R; Gutierrez-Orozco, F; Neilson, AP; Stephens, BR | 1 |
| Akagawa, M; Ishii, T; Kumazawa, S; Mizuno, D; Mori, T; Nakamura, Y; Nakayama, T; Tanaka, T; Yamaji, R | 1 |
| Kobayashi, D; Kuribayashi, K; Nirasawa, S; Onoda, C; Tanaka, M; Tsuji, N; Watanabe, N | 1 |
| Cai, SR; Chen, HY; He, YL; Wang, CY; Wang, Z; Zhan, WH; Zhang, CH; Zhu, BH | 1 |
| Cai, SR; Chen, HY; He, YL; Wang, Z; Zhan, WH; Zhang, CH; Zhu, BH | 1 |
| Wu, H; Xiao, Y; Xin, Y; Zhao, J | 1 |
| Joo, YE; Jung, YD; Khoi, PN; Lang, SA; Lee, YH; Park, JS; Stoeltzing, O | 1 |
| Cai, SR; He, YL; Li, ZR; Ma, JP; Peng, JS; Wang, Z; Zhan, WH; Zhang, CH; Zhu, BH | 1 |
| Ran, ZH; Tong, JL; Xiao, SD; Xu, Q | 1 |
| Fujiki, H; Inagake, M; Kitao, Y; Kuwata, K; Oya, K; Suganuma, M; Takahashi, T; Yamane, T | 1 |
| Aida, M; Fujiki, H; Kim, SJ; Nomura, T; Ochiai, Y; Okabe, S; Park, K; Suganuma, M | 1 |
| Hayakawa, S; Isemura, M; Kimura, T; Minami, T; Saeki, K; Sazuka, M | 1 |
| Aoyagi, Y; Hayakawa, S; Isemura, M; Kimura, T; Koyama, Y; Nakamura, Y; Noro, T; Saeki, K | 1 |
26 other study(ies) available for epigallocatechin gallate and Stomach Neoplasms
| Article | Year |
|---|---|
Chitosan-Gelatin-EGCG Nanoparticle-Meditated LncRNA TMEM44-AS1 Silencing to Activate the P53 Signaling Pathway for the Synergistic Reversal of 5-FU Resistance in Gastric Cancer.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Catechin; Cell Line, Tumor; Chitosan; Drug Resistance, Neoplasm; Fluorouracil; Gelatin; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Mice; MicroRNAs; Nanoparticles; Repressor Proteins; RNA; RNA, Antisense; RNA, Long Noncoding; Signal Transduction; Stomach Neoplasms; Tumor Suppressor Protein p53 | 2022 |
(-)-Epigallocatechin-3-gallate induced apoptosis by dissociation of c-FLIP/Ku70 complex in gastric cancer cells.
Topics: Apoptosis; CASP8 and FADD-Like Apoptosis Regulating Protein; Catechin; Cell Line, Tumor; Cell Proliferation; Humans; Stomach Neoplasms | 2023 |
Epigallocatechin gallate reverses gastric cancer by regulating the long noncoding RNA LINC00511/miR-29b/KDM2A axis.
Topics: Apoptosis; Carcinogenesis; Catechin; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; F-Box Proteins; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Jumonji Domain-Containing Histone Demethylases; MicroRNAs; RNA-Seq; RNA, Long Noncoding; Stomach Neoplasms | 2020 |
Epigallocatechin Gallate Enhances Inhibition Effect of DDP on the Proliferation of Gastric Cancer BGC-823 Cells by Regulating p19Arf-p53-p21Cip1 Signaling Pathway.
Topics: Antineoplastic Agents; Antioxidants; Catechin; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cisplatin; Cyclin-Dependent Kinase Inhibitor p19; Cyclin-Dependent Kinase Inhibitor p21; Humans; Signal Transduction; Stomach Neoplasms; Tumor Suppressor Protein p53 | 2021 |
Targeting Lactate Dehydrogenase A with Catechin Resensitizes SNU620/5FU Gastric Cancer Cells to 5-Fluorouracil.
Topics: Apoptosis; Catechin; Cell Line, Tumor; Drug Resistance, Neoplasm; Fluorouracil; Glycolysis; Humans; Lactate Dehydrogenase 5; Reactive Oxygen Species; Stomach; Stomach Neoplasms | 2021 |
Target challenging-cancer drug delivery to gastric cancer tissues with a fucose graft epigallocatechin-3-gallate-gold particles nanocomposite approach.
Topics: Animals; Antineoplastic Agents; Catechin; Cell Line, Tumor; Chitosan; Drug Carriers; Fucose; Gold; Helicobacter pylori; Humans; Kidney; Liver; Metal Nanoparticles; Mice; Microscopy, Electron, Transmission; Nanocomposites; Particle Size; Spectroscopy, Fourier Transform Infrared; Stomach Neoplasms; Transplantation, Heterologous; X-Ray Diffraction | 2018 |
Effects of EGCG on proliferation and apoptosis of gastric cancer SGC7901 cells via down-regulation of HIF-1α and VEGF under a hypoxic state.
Topics: Apoptosis; Catechin; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Drug Screening Assays, Antitumor; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Stomach Neoplasms; Vascular Endothelial Growth Factor A | 2019 |
Regulation of Id1 expression by epigallocatechin‑3‑gallate and its effect on the proliferation and apoptosis of poorly differentiated AGS gastric cancer cells.
Topics: Apoptosis; Catechin; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Differentiation Protein 1; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Stomach Neoplasms | 2013 |
Inhibition enhancer of zeste homologue 2 promotes senescence and apoptosis induced by doxorubicin in p53 mutant gastric cancer cells.
Topics: Apoptosis; Catechin; Cell Cycle Checkpoints; Cell Line, Tumor; Cellular Senescence; DNA Damage; Down-Regulation; Doxorubicin; Enhancer of Zeste Homolog 2 Protein; Humans; Mutation; Polycomb Repressive Complex 2; RNA Interference; RNA, Small Interfering; Stomach Neoplasms; Tumor Suppressor Protein p53 | 2014 |
Active Targeted Nanoparticles for Oral Administration of Gastric Cancer Therapy.
Topics: Administration, Oral; Animals; Apoptosis; Catechin; Chitosan; Drug Carriers; Gelatin; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms, Experimental; Polyethylene Glycols; Stomach Neoplasms | 2015 |
Inhibition of green tea polyphenol EGCG((-)-epigallocatechin-3-gallate) on the proliferation of gastric cancer cells by suppressing canonical wnt/β-catenin signalling pathway.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; beta Catenin; Catechin; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Humans; Male; Mice; Mice, Nude; Signal Transduction; Stomach Neoplasms; Tea; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2016 |
EGCG Suppresses ERK5 Activation to Reverse Tobacco Smoke-Triggered Gastric Epithelial-Mesenchymal Transition in BALB/c Mice.
Topics: Animals; Anticarcinogenic Agents; Benzodiazepinones; Biomarkers, Tumor; Carcinogenesis; Catechin; Dietary Supplements; Disease Models, Animal; Enzyme Activation; Epithelial-Mesenchymal Transition; Gastric Mucosa; Gene Expression Regulation, Neoplastic; Injections, Intraperitoneal; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase 7; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Random Allocation; Smoking; Stomach Neoplasms | 2016 |
[Epigallocatechin-3-gallate inhibits growth and angiogenesis of gastric cancer and its molecular mechanism].
Topics: Animals; Catechin; Cell Line, Tumor; Female; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Signal Transduction; STAT3 Transcription Factor; Stomach Neoplasms; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2009 |
Green and black tea inhibit cytokine-induced IL-8 production and secretion in AGS gastric cancer cells via inhibition of NF-κB activity.
Topics: Camellia sinensis; Catechin; Cell Line, Tumor; Chromatography, Liquid; Humans; Interleukin-1beta; Interleukin-8; MAP Kinase Signaling System; Mass Spectrometry; NF-kappa B; Plant Extracts; Stomach Neoplasms; Tea | 2010 |
(-)-Epigallocatechin-3-gallate suppresses growth of AZ521 human gastric cancer cells by targeting the DEAD-box RNA helicase p68.
Topics: Antineoplastic Agents; Apoptosis; Catechin; Cell Proliferation; DEAD-box RNA Helicases; Drug Screening Assays, Antitumor; Humans; Molecular Conformation; Stereoisomerism; Stomach Neoplasms; Structure-Activity Relationship; Tumor Cells, Cultured | 2011 |
(-)-Epigallocatechin-3-gallate induces apoptosis in gastric cancer cell lines by down-regulating survivin expression.
Topics: Anticarcinogenic Agents; Apoptosis; Catechin; Cell Line, Tumor; DNA-Binding Proteins; Down-Regulation; Humans; Inhibitor of Apoptosis Proteins; Nuclear Proteins; Stomach Neoplasms; Survivin; Tumor Protein p73; Tumor Suppressor Proteins | 2011 |
(-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer.
Topics: Anticarcinogenic Agents; Blotting, Western; Catechin; Cell Proliferation; Chromatin Immunoprecipitation; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Humans; In Vitro Techniques; Interleukin-6; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; STAT3 Transcription Factor; Stomach Neoplasms; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2011 |
[(-)-Epigallocatechin-3-gallate reduces vascular endothelial growth factor expression in gastric cancer cells via suppressing activity].
Topics: Catechin; Humans; Interleukin-6; RNA, Messenger; Signal Transduction; STAT3 Transcription Factor; Stomach Neoplasms; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2011 |
Low-dose docetaxel combined with (-)-epigallocatechin-3-gallate inhibits angiogenesis and tumor growth in nude mice with gastric cancer xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Catechin; Cell Proliferation; Docetaxel; Dose-Response Relationship, Drug; Drug Synergism; Humans; Immunoenzyme Techniques; Mice; Mice, Inbred BALB C; Mice, Nude; Microvessels; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Stomach Neoplasms; Taxoids; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2012 |
EGCG inhibits recepteur d'origine nantais expression by suppressing Egr-1 in gastric cancer cells.
Topics: Animals; Catechin; Cell Line, Tumor; DNA-Binding Proteins; Early Growth Response Protein 1; Enzyme Activation; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Plant Extracts; Promoter Regions, Genetic; Receptor Protein-Tyrosine Kinases; RNA Interference; RNA, Small Interfering; Stomach Neoplasms; Tea; Tetradecanoylphorbol Acetate; Transcription, Genetic; Xenograft Model Antitumor Assays | 2013 |
(-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis.
Topics: Animals; Anticarcinogenic Agents; Carcinoma; Catechin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Endothelial Cells; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; STAT3 Transcription Factor; Stomach Neoplasms; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2007 |
Apoptotic effect of Epigallocatechin-3-gallate on the human gastric cancer cell line MKN45 via activation of the mitochondrial pathway.
Topics: Anticarcinogenic Agents; Apoptosis; Caspase 3; Catechin; Cell Line, Tumor; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Membrane Potential, Mitochondrial; Mitochondria; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Stomach Neoplasms; Time Factors | 2007 |
Inhibition of N-methyl-N'-nitro-N-nitrosoguanidine-induced carcinogenesis by (-)-epigallocatechin gallate in the rat glandular stomach.
Topics: Adenocarcinoma; Adenoma; Animals; Antineoplastic Agents; Carcinoma, Papillary; Catechin; Drug Screening Assays, Antitumor; Male; Methylnitronitrosoguanidine; Ornithine Decarboxylase; Papilloma; Rats; Rats, Wistar; Stomach Neoplasms | 1995 |
Mechanistic aspects of green tea as a cancer preventive: effect of components on human stomach cancer cell lines.
Topics: 3T3 Cells; Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Catechin; Cell Division; Flavonoids; Gene Expression; Humans; Mice; Mice, Inbred BALB C; NF-kappa B; Okadaic Acid; Phenols; Phytotherapy; Polymers; Stomach Neoplasms; Tea; Transcription Factor AP-1; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1999 |
Tea catechins and related polyphenols as anti-cancer agents.
Topics: Anticarcinogenic Agents; Apoptosis; Catechin; Colonic Neoplasms; DNA Fragmentation; Flavonoids; Humans; Metalloendopeptidases; Phenols; Plant Extracts; Polymers; Stomach Neoplasms; Tea; Tumor Cells, Cultured; U937 Cells | 2000 |
Apoptosis-inducing activity of high molecular weight fractions of tea extracts.
Topics: Apoptosis; Catechin; DNA Fragmentation; Humans; Molecular Weight; Neoplasms; Plant Extracts; Stomach Neoplasms; Tea; Tumor Cells, Cultured; U937 Cells | 2001 |